Literature DB >> 9378494

Generation of dendritic cells from bone marrow progenitors using GM-CSF, TNF-alpha, and additional cytokines: antagonistic effects of IL-4 and IFN-gamma and selective involvement of TNF-alpha receptor-1.

F Lardon1, H W Snoeck, Z N Berneman, V F Van Tendeloo, G Nijs, M Lenjou, E Henckaerts, C J Boeckxtaens, P Vandenabeele, L L Kestens, D R Van Bockstaele, G L Vanham.   

Abstract

We report the generation of dendritic cells (DC) starting from CD34+ bone marrow (BM) progenitor cells, using a two-stage culture system in which, besides granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumour necrosis factor-alpha (TNF-alpha), stem-cell factor (SCF) was added during the first 5 days, while interleukin-4 (IL-4) and/or interferon-gamma (IFN-gamma) were added during the secondary culture period of 9 days. Addition of IL-4 favoured the outgrowth of CD1a+, HLA-DR+, CD4+, CD40+, CD80+ but CD14- cells with dendritic morphology and strong antigen-presenting capacity. Addition of IFN-gamma selectively induced HLA-DR and CD86 but did not up-regulate CD1a expression or antigen-presenting capacity of the differentiated cells. An antagonism between IL-4 and IFN-gamma could further be confirmed in that, as compared with IL-4 alone, the simultaneous addition of IL-4 and IFN-gamma to GM-CSF plus TNF-alpha during maturation reduced both the phenotypical (CD1a, CD4, CD40) and functional characteristics of DC. Using receptor-specific TNF-alpha mutants, we investigated the relative involvement of TNF-alpha receptors R1 and R2 in the generation of DC. The induction of CD1a and HLA-DR, as well as the increase in allostimulatory capacity were dependent on TNF-R1 triggering, whereas triggering through TNF-R2 had no measurable effect. We conclude first, that the expansion of DC from BM progenitors could most effectively be enhanced in a two-stage culture assay using SCF, GM-CSF, TNF-alpha and IL-4; second, that the effect of TNF-alpha in DC generation involves signalling via the TNF-R1 receptor; and third, that IFN-gamma counteracts some of the effects of IL-4 in DC generation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9378494      PMCID: PMC1363875          DOI: 10.1046/j.1365-2567.1997.00295.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

Review 1.  Dendritic cells: from ontogenetic orphans to myelomonocytic descendants.

Authors:  J H Peters; R Gieseler; B Thiele; F Steinbach
Journal:  Immunol Today       Date:  1996-06

2.  Molecular cloning and expression of a receptor for human tumor necrosis factor.

Authors:  T J Schall; M Lewis; K J Koller; A Lee; G C Rice; G H Wong; T Gatanaga; G A Granger; R Lentz; H Raab
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

3.  Interferon-gamma and interleukin-4 reciprocally regulate the production of monocytes/macrophages and neutrophils through a direct effect on committed monopotential bone marrow progenitor cells.

Authors:  H W Snoeck; F Lardon; M Lenjou; G Nys; D R Van Bockstaele; M E Peetermans
Journal:  Eur J Immunol       Date:  1993-05       Impact factor: 5.532

4.  Generation of DC from mouse spleen cell cultures in response to GM-CSF: immunophenotypic and functional analyses.

Authors:  L Lu; M Hsieh; T B Oriss; P A Morel; T E Starzl; A S Rao; A W Thomson
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

5.  GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells.

Authors:  C Caux; C Dezutter-Dambuyant; D Schmitt; J Banchereau
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

6.  Human TNF mutants with selective activity on the p55 receptor.

Authors:  X Van Ostade; P Vandenabeele; B Everaerdt; H Loetscher; R Gentz; M Brockhaus; W Lesslauer; J Tavernier; P Brouckaert; W Fiers
Journal:  Nature       Date:  1993-01-21       Impact factor: 49.962

7.  Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro.

Authors:  J Maciejewski; C Selleri; S Anderson; N S Young
Journal:  Blood       Date:  1995-06-01       Impact factor: 22.113

Review 8.  Interferon-gamma.

Authors:  E De Maeyer; J De Maeyer-Guignard
Journal:  Curr Opin Immunol       Date:  1992-06       Impact factor: 7.486

9.  Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation.

Authors:  M Cella; D Scheidegger; K Palmer-Lehmann; P Lane; A Lanzavecchia; G Alber
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

10.  Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.

Authors:  J W Young; P Szabolcs; M A Moore
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma.

Authors:  R Hájek; A W Butch
Journal:  Med Oncol       Date:  2000-02       Impact factor: 3.064

2.  Generation and characterization of chicken bone marrow-derived dendritic cells.

Authors:  Zhiguang Wu; Lisa Rothwell; John R Young; Jim Kaufman; Colin Butter; Pete Kaiser
Journal:  Immunology       Date:  2009-05-15       Impact factor: 7.397

3.  A new mechanism for inhalational priming: IL-4 bypasses innate immune signals.

Authors:  Anna M Dittrich; Hui-Chen Chen; Lan Xu; Patricia Ranney; Sean Connolly; Timur O Yarovinsky; H Kim Bottomly
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

4.  Phenotypic and functional abnormalities of bone marrow-derived dendritic cells in systemic lupus erythematosus.

Authors:  Ying J Nie; Mo Y Mok; Godfrey C F Chan; Albert W Chan; O U Jin; Sushma Kavikondala; Albert K W Lie; Chak S Lau
Journal:  Arthritis Res Ther       Date:  2010-05-18       Impact factor: 5.156

Review 5.  Cancer immunotherapy using RNA-loaded dendritic cells.

Authors:  P Ponsaerts; V F I Van Tendeloo; Z N Berneman
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

Review 6.  Dendritic cell vaccines in the treatment of multiple myeloma: advances and limitations.

Authors:  Tomas Büchler; Roman Hajek
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

7.  CSF-1 receptor structure/function in MacCsf1r-/- macrophages: regulation of proliferation, differentiation, and morphology.

Authors:  Wenfeng Yu; Jian Chen; Ying Xiong; Fiona J Pixley; Xu-Ming Dai; Yee-Guide Yeung; E Richard Stanley
Journal:  J Leukoc Biol       Date:  2008-06-17       Impact factor: 4.962

8.  Tumor necrosis factor alpha is a critical component of interleukin 13-mediated protective T helper cell type 2 responses during helminth infection.

Authors:  D Artis; N E Humphreys; A J Bancroft; N J Rothwell; C S Potten; R K Grencis
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

Review 9.  Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system.

Authors:  Ilse Van Brussel; Zwi N Berneman; Nathalie Cools
Journal:  Mediators Inflamm       Date:  2012-07-18       Impact factor: 4.711

10.  Transcriptional profiling of human dendritic cell populations and models--unique profiles of in vitro dendritic cells and implications on functionality and applicability.

Authors:  Kristina Lundberg; Ann-Sofie Albrekt; Inge Nelissen; Saskia Santegoets; Tanja D de Gruijl; Sue Gibbs; Malin Lindstedt
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.